Standard BioTools Return on Investment 2010-2024 | LAB
Current and historical return on investment (ROI) values for Standard BioTools (LAB) over the last 10 years.
| Standard BioTools ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2024-09-30 |
$-0.16B |
$0.49B |
-37.57% |
| 2024-06-30 |
$-0.15B |
$0.51B |
-40.94% |
| 2024-03-31 |
$-0.12B |
$0.58B |
-38.29% |
| 2023-12-31 |
$-0.08B |
$0.17B |
-32.31% |
| 2023-09-30 |
$-0.08B |
$0.24B |
-28.49% |
| 2023-06-30 |
$-0.08B |
$0.26B |
-29.47% |
| 2023-03-31 |
$-0.11B |
$0.28B |
-34.78% |
| 2022-12-31 |
$-0.12B |
$0.29B |
-43.94% |
| 2022-09-30 |
$-0.11B |
$0.31B |
-45.97% |
| 2022-06-30 |
$-0.10B |
$0.34B |
-50.13% |
| 2022-03-31 |
$-0.08B |
$0.12B |
-50.08% |
| 2021-12-31 |
$-0.07B |
$0.16B |
-40.48% |
| 2021-09-30 |
$-0.07B |
$0.16B |
-41.95% |
| 2021-06-30 |
$-0.06B |
$0.16B |
-31.39% |
| 2021-03-31 |
$-0.06B |
$0.18B |
-28.83% |
| 2020-12-31 |
$-0.05B |
$0.19B |
-26.12% |
| 2020-09-30 |
$-0.04B |
$0.21B |
-21.64% |
| 2020-06-30 |
$-0.05B |
$0.19B |
-25.97% |
| 2020-03-31 |
$-0.05B |
$0.20B |
-25.36% |
| 2019-12-31 |
$-0.05B |
$0.21B |
-23.83% |
| 2019-09-30 |
$-0.05B |
$0.21B |
-23.74% |
| 2019-06-30 |
$-0.05B |
$0.22B |
-23.37% |
| 2019-03-31 |
$-0.05B |
$0.23B |
-22.99% |
| 2018-12-31 |
$-0.05B |
$0.24B |
-23.03% |
| 2018-09-30 |
$-0.05B |
$0.19B |
-22.57% |
| 2018-06-30 |
$-0.05B |
$0.20B |
-23.31% |
| 2018-03-31 |
$-0.05B |
$0.21B |
-24.22% |
| 2017-12-31 |
$-0.06B |
$0.23B |
-25.85% |
| 2017-09-30 |
$-0.07B |
$0.23B |
-29.09% |
| 2017-06-30 |
$-0.07B |
$0.22B |
-29.05% |
| 2017-03-31 |
$-0.07B |
$0.23B |
-28.13% |
| 2016-12-31 |
$-0.07B |
$0.25B |
-26.94% |
| 2016-09-30 |
$-0.07B |
$0.26B |
-24.08% |
| 2016-06-30 |
$-0.06B |
$0.28B |
-19.62% |
| 2016-03-31 |
$-0.06B |
$0.29B |
-17.88% |
| 2015-12-31 |
$-0.05B |
$0.31B |
-15.73% |
| 2015-09-30 |
$-0.05B |
$0.32B |
-14.10% |
| 2015-06-30 |
$-0.05B |
$0.33B |
-15.26% |
| 2015-03-31 |
$-0.05B |
$0.34B |
-14.09% |
| 2014-12-31 |
$-0.05B |
$0.35B |
-14.69% |
| 2014-09-30 |
$-0.05B |
$0.35B |
-17.57% |
| 2014-06-30 |
$-0.04B |
$0.36B |
-21.67% |
| 2014-03-31 |
$-0.03B |
$0.36B |
-34.16% |
| 2013-12-31 |
$-0.02B |
|
inf% |
| 2013-09-30 |
$-0.02B |
|
inf% |
| 2013-06-30 |
$-0.02B |
|
inf% |
| 2013-03-31 |
$-0.02B |
|
inf% |
| 2012-12-31 |
$-0.02B |
|
inf% |
| 2012-09-30 |
$-0.02B |
|
-117.24% |
| 2012-06-30 |
$-0.02B |
|
-56.67% |
| 2012-03-31 |
$-0.02B |
|
-42.78% |
| 2011-12-31 |
$-0.02B |
$0.06B |
-29.01% |
| 2011-09-30 |
$-0.02B |
$0.06B |
-288.00% |
| 2011-06-30 |
$-0.02B |
$0.07B |
251.85% |
| 2011-03-31 |
$-0.01B |
$0.08B |
59.57% |
| 2010-12-31 |
$-0.01B |
$-0.18B |
33.14% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.562B |
$0.106B |
|
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
|
